Search
for
Sort by
Research 31–60 of 1000+
- A comparative study of efficacy of 5% minoxidil and 5% minoxidil plus platelet-rich plasma in same patient for treatment of androgenetic alopecia
- A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia
- The use of hormonal agents in the treatment of acne
- Hormonal Therapy for Acne
- Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo‐controlled study
- Cutaneous Side Effects of Oral Contraceptives
- Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK—ERK Signaling Pathway
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Lupus erythematosus: systemic and cutaneous manifestations
- Interferon in the treatment of cutaneous T-cell lymphoma
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy
- Cutaneous Manifestations of Eating Disorders
- Current management strategies for cutaneous T-cell lymphoma
- Fibromodulin reduces scar formation in adult cutaneous wounds by eliciting a fetal-like phenotype
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151
- Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- CUTANEOUS T-CELL LYMPHOMA
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Basic concepts, current evidence, and future potential for gene therapy in managing cutaneous wounds
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Isolation and Characterization of Cutaneous Epithelial Stem Cells
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cutaneous Reactions to Drugs
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- Imported cutaneous Leishmaniasis in Japan